S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TPST Tempest Therpeutics Inc

0.789799

-0.046 (-5.50%)

11 Mar 2025 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/08/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Rich Van Doren

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Tempest Therpeutics (NASDAQ:TPST)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Tempest Therpeutics Charts.

Tempest Therpeutics (NASDAQ:TPST)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Tempest Therpeutics Charts.

Tempest Therpeutics Inc News

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 12 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Tuesday 11 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 8 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Saturday 25 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
Tuesday 7 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 1 January 2025 (2 months ago) • Edgar (US Regulatory)

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 7 December 2024 (3 months ago) • GlobeNewswire Inc.

More Tempest Therpeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions